Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

Palvella Therapeutics’ drug candidate QTORIN rapamycin receives US patent: Wayne, Pennsylvania Saturday, June 21, 2025, 13:00 Hrs [IST] Palvella Therapeutics Inc, a clinical-sta ...

Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...

Virtual webinar on June 23, 2025 at 8:00 am ETNEWTOWN SQUARE, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated ...

Ovarian cancer remains a significant global health challenge, often diagnosed at an advanced stage due to non-specific ...

The Motley Fool. DATE Tuesday, June 17, 2025, at 4:30 p.m. EDT CALL PARTICIPANTS Chairman and Chief Executive Officer — ...

FDA approves Monjuvi (tafasitamab) for relapsed follicular lymphoma, offering hope with improved progression-free survival in ...

Lucy Hale, Troian Bellisario, Ashley Benson, Shay Mitchell, Sasha Pieterse, Ian Harding, Tyler Blackburn, Keegan Allen and ...

All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

Capricor Therapeutics (CAPR) announced four-year safety and efficacy results from its ongoing HOPE-2 Open-Label Extension study of Deramiocel, the Company’s lead cell therapy candidate for Duchenne ...

Capricor Therapeutics (NASDAQ:CAPR) plunged 32% following a trading halt on Friday after Stat News reported that the new head ...

Perverts and violent abusers are among the latest Welsh police officers kicked off the force. Through Freedom of Information ...